In this video, Dr. Correll discusses the role of the muscarinic receptor system in schizophrenia, exploring its impact on cognitive and functional outcomes. He examines the potential for targeting…

In this video, Dr. Correll examines the therapeutic potential of the muscarinic receptor system in schizophrenia treatment. He discusses how targeting muscarinic receptors may address cognitive and functional impairments,…

This video features Dr. Christoph Correll discussing the clinical application of muscarinic receptor modulators in schizophrenia treatment. He explores their unique mechanism of action, compares them to traditional antipsychotics,…

Research reveals shared cholinergic pathway dysfunction in schizophrenia and Alzheimer’s, leading to a new FDA-approved treatment.

In this video, Philip D. Harvey, PhD discusses the multifaceted nature of disability in schizophrenia, highlighting the impact of cognitive impairments, functional capacity, and negative symptoms on everyday outcomes…

In this video, Philip D. Harvey, PhD explores the use of digital phenotyping to track negative symptoms in schizophrenia. Through ecological momentary assessments (EMA) using GPS and actigraphy, the…